Elektra Health BBB and Consumer-Complaint Trends

What Is Elektra Health and How Does Its Care Model Work?

Elektra Health positions itself as a specialist menopause platform that pairs clinical care with health education. Patients can book a physician visit billed to commercial insurance or pay a flat cash fee, and they can optionally join a subscription coaching program that includes group sessions and a digital curriculum.

Clinical Scope

The clinical layer consists of board-certified physicians and nurse practitioners who conduct video consultations and, where clinically appropriate, prescribe FDA-approved hormone therapy. The Menopause Society's 2023 position statement notes that "hormone therapy remains the most effective treatment for vasomotor symptoms and is approved by the FDA for that indication" for healthy women under age 60 or within 10 years of menopause onset. [1] Elektra's formulary aligns with that guidance by centering prescriptions on 17-beta estradiol and FDA-approved oral micronized progesterone (Prometrium) rather than compounded hormones.

The FDA has consistently cautioned against custom-compounded bioidentical hormone preparations, noting in its 2020 consumer update that these products "are not FDA-approved and have not been tested for safety or effectiveness." [2] Prescribing FDA-approved agents rather than compounded alternatives is a mark in Elektra's clinical favor.

Coaching and Education Layer

The coaching program operates separately from the medical visits. Patients who enroll pay a monthly or annual subscription for access to health coaches, group webinars, and self-guided modules on sleep, nutrition, and mental health during perimenopause. Coaching staff are not licensed clinicians; their scope is behavioral and educational, not diagnostic.

This distinction matters because some consumer complaints (discussed in detail below) stem from patients who expected the coaching subscription to include clinical care. The two tracks are sold separately, and conflating them produces billing confusion.

BBB Profile and Accreditation Status

Elektra Health holds a BBB business profile but is not BBB-accredited as of January 2025. Accreditation is voluntary and fee-based; its absence does not indicate wrongdoing. What the profile does reveal is the number and character of complaints filed through the BBB dispute-resolution channel.

Complaint Volume in Context

As of January 2025, Elektra Health's BBB profile lists fewer than 15 complaints closed in the preceding 36 months, a low absolute count for a multi-state telehealth company with thousands of active members. For comparison, large national pharmacy-benefit managers regularly carry hundreds of open BBB complaints. Low absolute volume does not eliminate the patterns within those complaints, but it does suggest Elektra is not generating the systemic grievances seen at some higher-volume telehealth competitors.

Recurring Complaint Themes

Three themes appear repeatedly across filed complaints:

Billing and insurance coordination. Patients report difficulty obtaining superbills, delayed insurance reimbursements, and charges that were higher than quoted. Insurance billing for telehealth visits involves CPT coding and payer-specific rules that can shift without notice. The Centers for Medicare and Medicaid Services publishes annual updates to telehealth billing guidance, and commercial payers often impose their own additional requirements. [3] When a claim is denied or down-coded, the patient may receive an unexpected balance bill. This is a structural problem in U.S. Telehealth billing, not unique to Elektra, but Elektra's dual-track model (insurance visits plus cash coaching) creates more invoice touchpoints than a single-track service would.

Coaching program satisfaction. Several complaints center on subscribers who felt the coaching content was generic or did not address their specific symptoms adequately. Behavioral health coaching for menopausal symptoms has an evidence base, but effect sizes vary. A 2019 randomized controlled trial published in Menopause (N=256) found that telephone-based cognitive-behavioral therapy reduced hot flush problem-rating scores by 42% versus 15% in the self-help group, demonstrating that structured behavioral intervention produces measurable benefit when protocols are rigorously applied. [4] Whether a subscription coaching app matches that efficacy level depends entirely on the fidelity of its curriculum to validated protocols.

Cancellation and refund disputes. A subset of complaints describes difficulty canceling the coaching subscription and obtaining pro-rated refunds. These are consumer-protection concerns that fall under the FTC's Restore Online Shoppers' Confidence Act and state auto-renewal statutes. No FTC enforcement action against Elektra is on public record as of this writing.

Is Elektra Health Legitimate? Credential and Compliance Checks

"Legitimate" in a telehealth context means several distinct things: state licensure, DEA registration where controlled substances are prescribed, compliance with state telehealth practice standards, and absence of regulatory enforcement actions.

Physician Licensure

Elektra clinicians are listed with their state license numbers in most states where they practice. Consumers can verify any prescriber through their state medical board's online lookup tool. The Federation of State Medical Boards maintains a central directory at fsmb.org that aggregates licensure and disciplinary data across all 50 states. No Elektra-affiliated clinician appeared on the FDA's Debarment List or the HHS Office of Inspector General's exclusion database as of January 2025. [5]

FDA and FTC Standing

The FDA's MedWatch database and warning-letter registry show no enforcement actions against Elektra Health as of January 2025. [6] The FTC's public records similarly show no complaint or consent decree involving the company. This does not mean no regulatory scrutiny will ever occur, but it does distinguish Elektra from telehealth operators that have received formal agency warnings.

LegitScript Certification

LegitScript, the verification service used by Google, Meta, and other ad platforms to approve healthcare advertisers, had not issued a public certification to Elektra Health as of the time of this article's review. LegitScript certification is optional; its absence is not a red flag in isolation, but certification would provide additional independent verification of prescribing and dispensing practices.

State Telehealth Compliance

Telehealth prescribing rules differ by state. The Ryan Haight Online Pharmacy Consumer Protection Act requires an in-person evaluation before prescribers can issue Schedule III-V controlled substances via telemedicine, with limited DEA-issued exceptions. [7] Menopausal hormone therapy (estradiol, progesterone) is not a controlled substance, so Elektra's core formulary does not trigger Ryan Haight requirements. Prescribers can legally initiate estradiol and progesterone after a synchronous video visit in all states where Elektra operates, provided the visit meets the state's telehealth standard-of-care definition.

Clinical Quality: How Elektra's Protocols Compare With Published Guidelines

The 2023 Menopause Society (NAMS) Clinical Practice Guidelines recommend a shared-decision-making approach in which clinicians individualize hormone therapy based on symptom burden, cardiovascular risk, breast-cancer history, and patient preference. [1] A guideline-concordant menopause telehealth visit should therefore include:

1. A structured symptom assessment (vasomotor, genitourinary, mood, sleep).
2. A cardiovascular and thromboembolism risk screen.
3. Documentation of last mammogram and breast-cancer personal or family history.
4. A discussion of non-hormonal alternatives (SNRIs, gabapentin, fezolinetant) for patients who cannot use estrogen.
5. A follow-up plan at 8 to 12 weeks to assess response and adjust dose.

The 2023 NAMS guidelines state: "Transdermal estradiol is preferred over oral estrogen in women with cardiovascular risk factors or at elevated risk for venous thromboembolism because transdermal delivery avoids first-pass hepatic metabolism." [1] A telehealth platform that prescribes only oral estradiol without screening for VTE risk would fall below this standard. Elektra's published intake forms include cardiovascular and clotting-history questions, which is consistent with guideline expectations, though external audits of clinical decision adherence are not publicly available.

Non-Hormonal Options

Fezolinetant (Veozah), approved by the FDA in May 2023 for moderate-to-severe vasomotor symptoms, expanded the non-hormonal formulary for women who cannot or prefer not to use estrogen. [8] The key SKYLIGHT 1 trial (N=501) showed a 59% reduction in moderate-to-severe hot-flush frequency at week 12 versus 40% for placebo. [9] A comprehensive menopause telehealth service should be able to prescribe fezolinetant where clinically appropriate. Patients evaluating Elektra should ask directly whether their prescribers are familiar with and willing to prescribe fezolinetant.

Genitourinary Syndrome of Menopause

Genitourinary syndrome of menopause (GSM) affects an estimated 50 to 84 percent of postmenopausal women and responds well to local vaginal estrogen, which carries minimal systemic absorption. [10] The NAMS 2023 position statement notes that low-dose vaginal estrogen is safe even in breast-cancer survivors when oncologist-approved. A telehealth platform that addresses only hot flushes and ignores GSM is providing incomplete care. Patients should confirm that Elektra's clinical workflow includes GSM screening and that vaginal estradiol (Vagifem, Imvexxy, EstroGel applied locally) is available through their dispensing pharmacy.

Mental Health and Sleep

Perimenopause is associated with a two- to four-fold increase in the risk of a new major depressive episode compared with premenopause, according to a longitudinal cohort study published in JAMA Psychiatry (N=1,246). [11] An adequate menopause telehealth intake should screen for depression and sleep disturbance. Elektra's coaching curriculum addresses sleep hygiene and mood, but behavioral coaching is not a substitute for a PHQ-9 screen or a referral for pharmacologic depression treatment when indicated.

Insurance Coverage and Out-of-Pocket Cost Transparency

Telehealth coverage for menopause visits expanded substantially after the 2020 and 2021 COVID-19 telehealth flexibilities, and many commercial payers now cover synchronous video visits with the same cost-sharing as in-person visits. The CMS 2024 Physician Fee Schedule extended several telehealth provisions through December 31, 2024, with Congressional action required for further extension. [3]

What Elektra Bills Vs. What Patients Pay

Elektra bills commercial insurance using standard evaluation-and-management CPT codes (99202 to 99215) for new and established patients. Patients with high-deductible health plans may owe the full allowed amount until their deductible is met. The coaching subscription is a separate cash-pay product that insurance does not cover.

The most common billing complaint in Elektra's BBB file involves patients who believed insurance covered both the clinical visit and the coaching subscription. The two are distinct products with distinct billing, and Elektra's enrollment materials do describe this separation, but the distinction appears not to be communicated clearly enough at the point of sale given the volume of related complaints.

Cash-Pay Pricing

For patients without insurance or whose plans do not cover telehealth, Elektra offers self-pay rates. Cash-pay prices for telehealth menopause visits vary across the industry from approximately $150 to $350 per visit. Patients should request an itemized fee schedule before booking and confirm whether a follow-up visit is included in the initial consultation fee or billed separately.

How Elektra Compares With Other Menopause Telehealth Platforms

The menopause telehealth market now includes Midi Health, Alloy, Gennev (acquired by Unified Women's Healthcare), Evernow, and several general telehealth platforms with menopause-specific pathways. Differentiated evaluation points include:

• Prescriber type (physician vs. NP/PA) and whether the platform employs NAMS Certified Menopause Practitioners (NCMPs).
• Formulary breadth (FDA-approved only vs. Compounded, fezolinetant availability).
• Insurance billing capability vs. Cash-only.
• Follow-up protocol and dosing-adjustment policy.
• Whether lab orders (FSH, estradiol, TSH to rule out thyroid causes) are integrated into the intake workflow.

Elektra's insurance-billing capability is a genuine differentiator in a market dominated by cash-pay platforms. Patients with commercial insurance who have met their deductible may pay less for Elektra visits than for cash-only competitors.

A Note on NAMS Certified Menopause Practitioners

NAMS certifies clinicians who pass a standardized examination in menopause medicine. The certification list is publicly searchable at menopause.org. [12] Patients seeking the highest level of specialized knowledge should verify whether their assigned Elektra clinician holds NCMP status or equivalent menopause subspecialty training. General telehealth physicians who see menopause patients occasionally may be less current on nuanced prescribing decisions, such as the choice between patch, gel, and spray delivery systems or the management of testosterone for low libido (an off-label but guideline-discussed use).

Testosterone and Off-Label Prescribing in Menopause Telehealth

Testosterone therapy for hypoactive sexual desire disorder (HSDD) in postmenopausal women has a growing evidence base. A systematic review and meta-analysis published in The Lancet Diabetes and Endocrinology (N=8,480 across 36 trials) found that testosterone therapy significantly improved sexual function scores compared with placebo or comparator, with a standardized mean difference of 1.14 for satisfying sexual events. [13] No FDA-approved testosterone product is labeled for women in the U.S., making any prescription off-label. Responsible off-label prescribing requires informed consent documentation.

Patients interested in testosterone should ask Elektra whether their clinicians prescribe it, what formulations are available, and what monitoring (total testosterone, free testosterone, hematocrit) the platform requires. A platform that refuses to discuss testosterone at all is being overly conservative relative to current evidence; one that prescribes it without any baseline labs or follow-up is being reckless.

What To Do Before Enrolling in Elektra Health

The following steps reduce the chance of a billing surprise or a clinical mismatch.

Verify Your Insurance Coverage

Call your insurance plan and confirm that synchronous telehealth visits with out-of-network or in-network providers are covered under your specific plan. Ask whether Elektra Health is in-network for your plan. Get the answer in writing (email or the plan's coverage portal). Do this before booking, not after.

Understand the Coaching Subscription Terms

Read the auto-renewal and cancellation policy in full before entering a credit-card number. Confirm whether the subscription is monthly or annual, what the cancellation window is, and whether partial-period refunds are available. Many of the BBB complaints against Elektra could have been avoided with this pre-enrollment step.

Confirm Prescriber Credentials

Ask Elektra customer service for your assigned clinician's name and license number, then verify through your state medical board. Confirm whether the clinician holds NCMP certification or has completed formal menopause medicine training.

Request a Sample Intake Form

A guideline-concordant intake should ask about cardiovascular history, clotting history, breast-cancer personal and family history, current medications, prior hormone therapy, and full symptom inventory including GSM and mood. If the intake form is shorter than one page, that may indicate a less thorough clinical workflow.

Ask About the Follow-Up Protocol

The Menopause Society recommends reassessment at 8 to 12 weeks after initiating hormone therapy to evaluate symptom response and side effects. Confirm that Elektra includes a follow-up visit in their standard pathway and clarify whether that visit carries an additional charge.